Guilhem Royer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guilhem Royer has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
- Erick Denamur
Université Sorbonne Paris Nord et Université Paris Cité, INSERM, IAME, Paris, France
15 shared publications Olivier Clermont
Université Sorbonne Paris Nord et Université Paris Cité, INSERM, IAME, Paris, France
9 shared publications- Bénédicte Condamine
Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME
6 shared publications - Marco Galardini
Institute for Molecular Bacteriology, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany
6 shared publications - Hervé Jacquier
Unité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpitaux Universitaires Henri Mondor, AP-HP , Créteil
5 shared publications - Jean-Winoc Decousser
Infection Control Unit, Microbiology Department, University Hospital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France; Dynamyc EA 7380, Université Paris-Est Créteil, USC Anses, Créteil, France
5 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (11)
Shotgun Metagenomics Versus 16S rDNA Sanger Sequencing for the Diagnosis of Blood Culture-Negative Endocarditis: A Draw?
Although valuable for diagnosing blood culture-negative infective endocarditis, 16S rDNA sequencing and metagenomics on valve/vegetation have never been compared using identical DNA extracts. We compared methods on surgical samples from definite, possible, and rejected infective endocarditis involving culture-negative native valves. Positivity rates were similar, with taxonomic resolution being higher for metagenomics.
- 31 October 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (11)
Open AccessShotgun Metagenomics Versus 16S rDNA Sanger Sequencing for the Diagnosis of Blood Culture-Negative Endocarditis: A Draw?
Although valuable for diagnosing blood culture-negative infective endocarditis, 16S rDNA sequencing and metagenomics on valve/vegetation have never been compared using identical DNA extracts. We compared methods on surgical samples from definite, possible, and rejected infective endocarditis involving culture-negative native valves. Positivity rates were similar, with taxonomic resolution being higher for metagenomics.
- Open Access
- 5 August 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (8) , e0167925
Influence of iron uptake systems on cefiderocol activity in Escherichia coli : At the crossroads of antibiotic resistance and virulence
Cefiderocol (FDC) is a new siderophore-conjugated cephalosporin that enters the periplasm via iron transport systems. However, the specific contribution of individual iron uptake pathways to FDC activity remains unclear. We investigated the role of 13 iron acquisition systems using several Escherichia coli strain collections. FDC MICs were determined in iron-depleted and iron-supplemented media for E. coli mutants (Keio and pathogenic island [PAI]-deleted collections) and for no-acquired β-lactamase or TEM (NoBL/TEM- Ec ) and NDM-producing E. coli (NDM- Ec ) clinical isolates. Prevalence of iron uptake genes was assessed in these isolates, and fec operon prevalence and genomic location were investigated in E. coli genomes from EnteroBase and RefSeq databases. Compared to K-12 and 536 reference E. coli , only Δ cirA and Δ fiu (enterobactin system) showed increased FDC MICs (8- and 3-fold, respectively), while Δ fecA and Δ fecB had lower MICs (3-fold decrease). The fec operon, a known extraintestinal virulence factor, was significantly more prevalent in isolates with FDC MICs above median than below (96% vs. 33% in NoBL/TEM- Ec ; 100% vs. 0% in NDM- Ec ). According to EUCAST breakpoints, 63.6% of fec -positive NDM- Ec were resistant to FDC, whereas none of the fec -negative were. The fec operon was found in 46.5% of E. coli genomes, including virulent clones (ST131, 77%) and was mostly chromosome-borne (99%). Plasmid-borne fec closely resembled that of Enterobacter hormaechei or Klebsiella pneumoniae , suggesting interspecies transfer. Our findings highlight the role of Fec in reducing FDC susceptibility and promoting resistance in NDM-producing E. coli . They challenge the virulence-resistance trade-off demonstrating the “liaisons dangereuses” between iron and antibiotics.
- 5 August 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (8) , e0167925
Open AccessInfluence of iron uptake systems on cefiderocol activity in Escherichia coli : At the crossroads of antibiotic resistance and virulence
Cefiderocol (FDC) is a new siderophore-conjugated cephalosporin that enters the periplasm via iron transport systems. However, the specific contribution of individual iron uptake pathways to FDC activity remains unclear. We investigated the role of 13 iron acquisition systems using several Escherichia coli strain collections. FDC MICs were determined in iron-depleted and iron-supplemented media for E. coli mutants (Keio and pathogenic island [PAI]-deleted collections) and for no-acquired β-lactamase or TEM (NoBL/TEM- Ec ) and NDM-producing E. coli (NDM- Ec ) clinical isolates. Prevalence of iron uptake genes was assessed in these isolates, and fec operon prevalence and genomic location were investigated in E. coli genomes from EnteroBase and RefSeq databases. Compared to K-12 and 536 reference E. coli , only Δ cirA and Δ fiu (enterobactin system) showed increased FDC MICs (8- and 3-fold, respectively), while Δ fecA and Δ fecB had lower MICs (3-fold decrease). The fec operon, a known extraintestinal virulence factor, was significantly more prevalent in isolates with FDC MICs above median than below (96% vs. 33% in NoBL/TEM- Ec ; 100% vs. 0% in NDM- Ec ). According to EUCAST breakpoints, 63.6% of fec -positive NDM- Ec were resistant to FDC, whereas none of the fec -negative were. The fec operon was found in 46.5% of E. coli genomes, including virulent clones (ST131, 77%) and was mostly chromosome-borne (99%). Plasmid-borne fec closely resembled that of Enterobacter hormaechei or Klebsiella pneumoniae , suggesting interspecies transfer. Our findings highlight the role of Fec in reducing FDC susceptibility and promoting resistance in NDM-producing E. coli . They challenge the virulence-resistance trade-off demonstrating the “liaisons dangereuses” between iron and antibiotics.
- 27 May 2026
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 39 (3) , e0027425
Dissemination of ESBL-producing Escherichia coli and carriage in the community worldwide: epidemiology, transmission pathways, molecular insights, and practical aspects
SUMMARY: Since the worldwide dissemination of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-Ec) in the early 2000s, ESBL-Ec community carriage has followed divergent epidemiological patterns across regions. Currently, high-income countries (HIC) have a lower prevalence of ESBL-Ec carriage compared to the more concerning prevalence observed in low- and middle-income countries (LMICs). The aim of this review is to summarize the factors that could explain variations in ESBL-Ec prevalence by bridging together information from epidemiological, clinical, and bacterial genetic data. First, geographical differences in ESBL-Ec carriage in the community could be partly related to disparities in socioeconomic levels (e.g., country-level income, Human Development Index) and their associated conditions. Few risk factors associated with ESBL-Ec carriage overlap between LMICs and HICs, except for antibiotic use. Transmission across human, animal, and environmental sectors is much more common in LMICs, whereas inter-human transmission in HICs is more prominent. From the available molecular data, distinct bacterial genetic backgrounds between LMICs (predominantly A and B1 E. coli phylogroups) and HICs (predominantly B2 phylogroup) highlight the clones able to successfully disseminate in these settings. As the dissemination of ESBL-Ec is driven by a complex interplay of socioeconomic, behavioral, and bacterial genetic factors, tailored public health strategies, including antibiotic stewardship and innovative strategies discussed herein, are essential to curb further increases in their prevalence.
- 27 May 2026
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 39 (3) , e0027425
Dissemination of ESBL-producing Escherichia coli and carriage in the community worldwide: epidemiology, transmission pathways, molecular insights, and practical aspects
SUMMARY: Since the worldwide dissemination of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-Ec) in the early 2000s, ESBL-Ec community carriage has followed divergent epidemiological patterns across regions. Currently, high-income countries (HIC) have a lower prevalence of ESBL-Ec carriage compared to the more concerning prevalence observed in low- and middle-income countries (LMICs). The aim of this review is to summarize the factors that could explain variations in ESBL-Ec prevalence by bridging together information from epidemiological, clinical, and bacterial genetic data. First, geographical differences in ESBL-Ec carriage in the community could be partly related to disparities in socioeconomic levels (e.g., country-level income, Human Development Index) and their associated conditions. Few risk factors associated with ESBL-Ec carriage overlap between LMICs and HICs, except for antibiotic use. Transmission across human, animal, and environmental sectors is much more common in LMICs, whereas inter-human transmission in HICs is more prominent. From the available molecular data, distinct bacterial genetic backgrounds between LMICs (predominantly A and B1 E. coli phylogroups) and HICs (predominantly B2 phylogroup) highlight the clones able to successfully disseminate in these settings. As the dissemination of ESBL-Ec is driven by a complex interplay of socioeconomic, behavioral, and bacterial genetic factors, tailored public health strategies, including antibiotic stewardship and innovative strategies discussed herein, are essential to curb further increases in their prevalence.
- Open Access
- 6 May 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (5) , e0168225
Piperacillin-tazobactam resistance in Klebsiella pneumoniae is often associated with IS 26- mediated bla SHV-1 amplification in a widespread Klebsiella -adapted plasmid
Piperacillin-tazobactam (TZP) resistance in Klebsiella pneumoniae involves diverse mechanisms with unclear prevalence and phenotypic impact. To elucidate these mechanisms, we analyzed K. pneumoniae clinical isolates resistant to TZP but susceptible to cefotaxime and cefepime. Among 53 isolates, 14 were further studied by MIC testing for TZP, amoxicillin-clavulanic acid (AMC), and ceftazidime (CAZ). Short-read sequencing was performed for all 14 isolates and long-read sequencing for two. Core-genome MLST showed that all were unrelated. Two had a bla OXA-1 gene, one also carrying an ompK35 porin gene mutation; two others had the same mutation in the promoter of the chromosomal copy of bla SHV usually associated with overexpression. In the remaining 10, resistance correlated with plasmid-borne bla SHV-1 copies. Nine isolates carried bla SHV-1v1 in the same IS 26 pseudocompound transposon (PTn), corresponding to PTnSHV-L and located on a conserved IncFIB(K)_1_Kpn3 plasmid in eight. The tenth isolate carried PTnSHV-L with a distinct bla SHV-1 variant on both an IncHI1B_1_pNDM-MAR plasmid and a high-copy-number Col-type plasmid. Read depth analysis confirmed that bla SHV copy number correlated with TZP, AMC, and CAZ MICs. Large-scale database screening identified related IncFIB(K)_1_Kpn3 plasmids, strongly associated with K. pneumoniae and frequently carrying a PTnSHV-L marker. Analysis of a K. pneumoniae genome data set confirmed the frequent co-occurrence of this plasmid and the PTnSHV-L marker in strains with multiple bla SHV copies. These findings suggest the emergence of an epidemic plasmid adapted to K. pneumoniae and driving TZP resistance through bla SHV-1 amplification, underscoring the need for genomic surveillance to detect amplification-based resistance overlooked by standard phenotypic or PCR assays.
- 6 May 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (5) , e0168225
Open AccessPiperacillin-tazobactam resistance in Klebsiella pneumoniae is often associated with IS 26- mediated bla SHV-1 amplification in a widespread Klebsiella -adapted plasmid
Piperacillin-tazobactam (TZP) resistance in Klebsiella pneumoniae involves diverse mechanisms with unclear prevalence and phenotypic impact. To elucidate these mechanisms, we analyzed K. pneumoniae clinical isolates resistant to TZP but susceptible to cefotaxime and cefepime. Among 53 isolates, 14 were further studied by MIC testing for TZP, amoxicillin-clavulanic acid (AMC), and ceftazidime (CAZ). Short-read sequencing was performed for all 14 isolates and long-read sequencing for two. Core-genome MLST showed that all were unrelated. Two had a bla OXA-1 gene, one also carrying an ompK35 porin gene mutation; two others had the same mutation in the promoter of the chromosomal copy of bla SHV usually associated with overexpression. In the remaining 10, resistance correlated with plasmid-borne bla SHV-1 copies. Nine isolates carried bla SHV-1v1 in the same IS 26 pseudocompound transposon (PTn), corresponding to PTnSHV-L and located on a conserved IncFIB(K)_1_Kpn3 plasmid in eight. The tenth isolate carried PTnSHV-L with a distinct bla SHV-1 variant on both an IncHI1B_1_pNDM-MAR plasmid and a high-copy-number Col-type plasmid. Read depth analysis confirmed that bla SHV copy number correlated with TZP, AMC, and CAZ MICs. Large-scale database screening identified related IncFIB(K)_1_Kpn3 plasmids, strongly associated with K. pneumoniae and frequently carrying a PTnSHV-L marker. Analysis of a K. pneumoniae genome data set confirmed the frequent co-occurrence of this plasmid and the PTnSHV-L marker in strains with multiple bla SHV copies. These findings suggest the emergence of an epidemic plasmid adapted to K. pneumoniae and driving TZP resistance through bla SHV-1 amplification, underscoring the need for genomic surveillance to detect amplification-based resistance overlooked by standard phenotypic or PCR assays.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Génomique comparée à grande échelle de souches d’Escherichia coli responsables de bactériémies chez l’Homme : implications cliniques et analyse des réseaux métaboliques
Escherichia coli est la bactérie aéro-anaérobie facultative majoritaire du tube digestif de l'Homme et, également, l'espèce la plus fréquemment isolée au cours de bactériémies dans les pays industrialisés. La population de E. coli présente une diversité importante mais néanmoins structurée, avec certains groupes phylogénétiques préférentiellement associés à un mode de vie (e.g. A/B1 et commensal, B2/D et pathogène extraintestinal). De nombreux facteurs de virulence ont été décrits chez les souches pathogènes extraintestinales (ExPEC), mais le pronostic des bactériémies à E. coli semble dépendre des facteurs associés à l'hôte. Cependant, certains clones virulents et multirésistants aux antibiotiques ont récemment émergé, modifiant drastiquement l'épidémiologie de ces infections. En parallèle, la démocratisation des méthodes de séquençage offre aujourd'hui une granularité encore jamais atteinte dans l'analyse des génomes bactériens. L'objectif de ce travail de thèse est de tirer profit des méthodes de génomique comparée pour améliorer notre compréhension de la physiopathologie des bactériémies à E. coli, tout en prenant en compte les modifications épidémiologiques majeures qui sont observées. La réalisation de telles comparaisons génomiques a nécessité, tout d'abord, la mise en place d'une stratégie d'analyse, incluant notamment le développement d'une approche ciblée pour l'identification des séquences plasmidiques au sein d'assemblages de génomes.Cette stratégie, appliquée à 545 souches recueillies au cours de l'étude Septicoli en 2016-2017, a permis de confirmer le rôle mineur des déterminants bactériens dans l'issue des bactériémies à E. coli. De plus, par la comparaison de ces souches à celles de l'étude Colibafi, nous avons étudié la dynamique de la population sur 12 ans. Si celle-ci apparaît globalement stable, l'exploration plus fine des principaux clones montre d'importants remaniements, parfois associés à des facteurs de virulence typiques des ExPEC. D'autre part, la diversité antigénique de ces clones est variable et suggère des pressions de sélection différentes en fonction de leur niche écologique respective. Enfin, dans une dernière partie nous avons réalisé la reconstruction des réseaux métaboliques de plus de 1400 souches de E. coli afin d'étudier les liens entre métabolisme et mode de vie. Les résultats soulignent la conservation du métabolisme chez E. coli et son association forte avec la phylogénie. Par ailleurs, une analyse détaillée des principaux clones retrouvés dans les bactériémies, dont notamment le ST131, met en évidence une voie métabolique impliquée dans la dégradation de composés aromatiques dérivés de la lignine. Cette voie, habituellement absente des souches de phylogroupe B2, pourrait procurer un avantage sélectif à ce clone pandémique mondial d'émergence récente.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Génomique comparée à grande échelle de souches d’Escherichia coli responsables de bactériémies chez l’Homme : implications cliniques et analyse des réseaux métaboliques
Escherichia coli est la bactérie aéro-anaérobie facultative majoritaire du tube digestif de l'Homme et, également, l'espèce la plus fréquemment isolée au cours de bactériémies dans les pays industrialisés. La population de E. coli présente une diversité importante mais néanmoins structurée, avec certains groupes phylogénétiques préférentiellement associés à un mode de vie (e.g. A/B1 et commensal, B2/D et pathogène extraintestinal). De nombreux facteurs de virulence ont été décrits chez les souches pathogènes extraintestinales (ExPEC), mais le pronostic des bactériémies à E. coli semble dépendre des facteurs associés à l'hôte. Cependant, certains clones virulents et multirésistants aux antibiotiques ont récemment émergé, modifiant drastiquement l'épidémiologie de ces infections. En parallèle, la démocratisation des méthodes de séquençage offre aujourd'hui une granularité encore jamais atteinte dans l'analyse des génomes bactériens. L'objectif de ce travail de thèse est de tirer profit des méthodes de génomique comparée pour améliorer notre compréhension de la physiopathologie des bactériémies à E. coli, tout en prenant en compte les modifications épidémiologiques majeures qui sont observées. La réalisation de telles comparaisons génomiques a nécessité, tout d'abord, la mise en place d'une stratégie d'analyse, incluant notamment le développement d'une approche ciblée pour l'identification des séquences plasmidiques au sein d'assemblages de génomes.Cette stratégie, appliquée à 545 souches recueillies au cours de l'étude Septicoli en 2016-2017, a permis de confirmer le rôle mineur des déterminants bactériens dans l'issue des bactériémies à E. coli. De plus, par la comparaison de ces souches à celles de l'étude Colibafi, nous avons étudié la dynamique de la population sur 12 ans. Si celle-ci apparaît globalement stable, l'exploration plus fine des principaux clones montre d'importants remaniements, parfois associés à des facteurs de virulence typiques des ExPEC. D'autre part, la diversité antigénique de ces clones est variable et suggère des pressions de sélection différentes en fonction de leur niche écologique respective. Enfin, dans une dernière partie nous avons réalisé la reconstruction des réseaux métaboliques de plus de 1400 souches de E. coli afin d'étudier les liens entre métabolisme et mode de vie. Les résultats soulignent la conservation du métabolisme chez E. coli et son association forte avec la phylogénie. Par ailleurs, une analyse détaillée des principaux clones retrouvés dans les bactériémies, dont notamment le ST131, met en évidence une voie métabolique impliquée dans la dégradation de composés aromatiques dérivés de la lignine. Cette voie, habituellement absente des souches de phylogroupe B2, pourrait procurer un avantage sélectif à ce clone pandémique mondial d'émergence récente.
- Open Access
- 19 March 2026
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 208 (3) , e0042125
Identification of specific metabolic capacities associated with major extraintestinal pathogenic Escherichia coli lineages
Bacterial niche colonization relies on multiple factors, among which the metabolic capacity to utilize specific substrates is pivotal. As a gut commensal of humans and other vertebrates acting as an intestinal and extraintestinal opportunistic pathogen, Escherichia coli faces such environmental pressures. We therefore aimed to identify (i) metabolic patterns associated with E. coli lifestyle (commensal versus extraintestinal pathogenic E. coli [ExPEC]) and (ii) ExPEC-specific metabolic features that could help explain the emergence and success of major pandemic clones. Using a pangenomic framework coupled with metabolic pathway prediction, we analyzed 1,498 well-characterized E. coli strains collected over 17 years in France, including adult commensal strains ( n = 370) and ExPEC strains involved in severe infections (bloodstream infections from various portals of entry and pneumonia) ( n = 1,128). Although metabolism was more conserved than gene content, substantial metabolic diversity was observed, with over 50% pathways being variable, mainly involving biosynthetic and degradation processes. No pathway was specifically associated with lifestyle; metabolic profiles primarily reflected phylogeny. However, several clone-specific metabolic capacities were identified. Some may support extraintestinal survival during infection, such as the 5’-deoxynucleoside recycling pathway enriched in the major ExPEC clone STc69 from phylogroup D. Conversely, in phylogroup B2, clone-specific pathways enabled the degradation of plant-derived compounds, potentially facilitating gut colonization through niche-defining nutrients. Notably, D-apiose degradation pathway analysis revealed a functional pathway strongly associated with the pandemic clones STc131 and STc14. Overall, these lineage-specific metabolic capacities may contribute to the ecological success and dissemination of dominant ExPEC clones. IMPORTANCE: According to the nutrient-niche hypothesis, bacteria must exploit distinct substrates to grow and persist in their various habitats. Such niche differentiation is at play among the commensal and pathogenic E. coli populations. With this in mind, we search for specific associations between metabolic pathways and strain origin (commensal versus severe extraintestinal infections). Metabolic profiles were predominantly shaped by phylogeny, reflecting the species’ clonal structure and the close link between phylogenetic background and lifestyle. Among the lineage-specific determinants, we identified several pathways associated with worldwide spread clones responsible for bloodstream infections, supporting the existence of clone-specific strategies for niche adaptation.
- 19 March 2026
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 208 (3) , e0042125
Open AccessIdentification of specific metabolic capacities associated with major extraintestinal pathogenic Escherichia coli lineages
Bacterial niche colonization relies on multiple factors, among which the metabolic capacity to utilize specific substrates is pivotal. As a gut commensal of humans and other vertebrates acting as an intestinal and extraintestinal opportunistic pathogen, Escherichia coli faces such environmental pressures. We therefore aimed to identify (i) metabolic patterns associated with E. coli lifestyle (commensal versus extraintestinal pathogenic E. coli [ExPEC]) and (ii) ExPEC-specific metabolic features that could help explain the emergence and success of major pandemic clones. Using a pangenomic framework coupled with metabolic pathway prediction, we analyzed 1,498 well-characterized E. coli strains collected over 17 years in France, including adult commensal strains ( n = 370) and ExPEC strains involved in severe infections (bloodstream infections from various portals of entry and pneumonia) ( n = 1,128). Although metabolism was more conserved than gene content, substantial metabolic diversity was observed, with over 50% pathways being variable, mainly involving biosynthetic and degradation processes. No pathway was specifically associated with lifestyle; metabolic profiles primarily reflected phylogeny. However, several clone-specific metabolic capacities were identified. Some may support extraintestinal survival during infection, such as the 5’-deoxynucleoside recycling pathway enriched in the major ExPEC clone STc69 from phylogroup D. Conversely, in phylogroup B2, clone-specific pathways enabled the degradation of plant-derived compounds, potentially facilitating gut colonization through niche-defining nutrients. Notably, D-apiose degradation pathway analysis revealed a functional pathway strongly associated with the pandemic clones STc131 and STc14. Overall, these lineage-specific metabolic capacities may contribute to the ecological success and dissemination of dominant ExPEC clones. IMPORTANCE: According to the nutrient-niche hypothesis, bacteria must exploit distinct substrates to grow and persist in their various habitats. Such niche differentiation is at play among the commensal and pathogenic E. coli populations. With this in mind, we search for specific associations between metabolic pathways and strain origin (commensal versus severe extraintestinal infections). Metabolic profiles were predominantly shaped by phylogeny, reflecting the species’ clonal structure and the close link between phylogenetic background and lifestyle. Among the lineage-specific determinants, we identified several pathways associated with worldwide spread clones responsible for bloodstream infections, supporting the existence of clone-specific strategies for niche adaptation.
- Open Access
- 4 March 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (3) , e0120725
The mecillinam resistome in Klebsiella pneumoniae : how resistance to a one-target β-lactam triggers a diversity of responses
Antimicrobial resistance is a silent pandemic responsible for 1.14 million deaths worldwide in 2021, with a major contribution from Klebsiella pneumoniae . β-lactams are the most commonly used antibiotics in humans, and there is an urgent need to characterize the resistance mechanisms to these antibiotics in Enterobacterales other than Escherichia coli . Mecillinam is a narrow-spectrum β-lactam targeting a single penicillin-binding protein, PBP2. Pivmecillinam, its oral prodrug, is used as a first-line treatment for uncomplicated urinary tract infections. It has been used for decades in Europe but was only authorized by the US Food and Drug Administration in 2024. Here, we decipher mecillinam resistance mechanisms in K. pneumoniae by characterizing its resistome in a pan-susceptible strain. The chromosomally encoded SHV β-lactamase led to spontaneous mecillinam-resistant mutants appearing at a higher rate, growing faster and at higher mecillinam concentrations in K. pneumoniae than in E. coli . The most frequent genetic event was an unstable duplication leading to heteroresistance. The selected mutations leading to resistance affected a wide range of functions, with resistance being dependent or independent of the RelA (p)ppGpp synthetase. Through an in-depth characterization of six mutant strains, we showed that, in the presence of mecillinam, they all experienced different growth defects despite high minimal inhibitory concentrations. Overall, our results in K. pneumoniae suggest different mechanisms to escape the complex mode of action of β-lactams in synergy with the β-lactamase SHV.
- 4 March 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (3) , e0120725
Open AccessThe mecillinam resistome in Klebsiella pneumoniae : how resistance to a one-target β-lactam triggers a diversity of responses
Antimicrobial resistance is a silent pandemic responsible for 1.14 million deaths worldwide in 2021, with a major contribution from Klebsiella pneumoniae . β-lactams are the most commonly used antibiotics in humans, and there is an urgent need to characterize the resistance mechanisms to these antibiotics in Enterobacterales other than Escherichia coli . Mecillinam is a narrow-spectrum β-lactam targeting a single penicillin-binding protein, PBP2. Pivmecillinam, its oral prodrug, is used as a first-line treatment for uncomplicated urinary tract infections. It has been used for decades in Europe but was only authorized by the US Food and Drug Administration in 2024. Here, we decipher mecillinam resistance mechanisms in K. pneumoniae by characterizing its resistome in a pan-susceptible strain. The chromosomally encoded SHV β-lactamase led to spontaneous mecillinam-resistant mutants appearing at a higher rate, growing faster and at higher mecillinam concentrations in K. pneumoniae than in E. coli . The most frequent genetic event was an unstable duplication leading to heteroresistance. The selected mutations leading to resistance affected a wide range of functions, with resistance being dependent or independent of the RelA (p)ppGpp synthetase. Through an in-depth characterization of six mutant strains, we showed that, in the presence of mecillinam, they all experienced different growth defects despite high minimal inhibitory concentrations. Overall, our results in K. pneumoniae suggest different mechanisms to escape the complex mode of action of β-lactams in synergy with the β-lactamase SHV.
- Open Access
Spatiotemporal dynamics of β-lactam-resistant E. coli in young diseased calves in Wallonia, Belgium
Calves are one of the most common carriers of antibiotic-resistant bacteria among farm animals. However, the impact of antibiotic usage on resistance mechanisms, transmission routes between farms, and the transmission of resistant bacteria to humans remain largely unknown. Here we analyzed the population of β-lactam resistant E. coli isolated over five calving seasons on 444 farms scattered throughout Wallonia, Belgium. Restrictions on critical antibiotics usage led to a reduction of resistance to 3 rd generation cephalosporins but has no impact on population structure and β-lactamase genes indicating a resilient population. The correlation between short genetic distances and geographic proximity suggests indirect transmission between farms by fomites with differences between regions east and west of the river Meuse. Phylogenetic analysis of calf isolates with isolates from public databases indicates transitions from bovine to human adaptation. These findings provide new means to further model the spread of E. coli in livestock farming.
Open AccessSpatiotemporal dynamics of β-lactam-resistant E. coli in young diseased calves in Wallonia, Belgium
Calves are one of the most common carriers of antibiotic-resistant bacteria among farm animals. However, the impact of antibiotic usage on resistance mechanisms, transmission routes between farms, and the transmission of resistant bacteria to humans remain largely unknown. Here we analyzed the population of β-lactam resistant E. coli isolated over five calving seasons on 444 farms scattered throughout Wallonia, Belgium. Restrictions on critical antibiotics usage led to a reduction of resistance to 3 rd generation cephalosporins but has no impact on population structure and β-lactamase genes indicating a resilient population. The correlation between short genetic distances and geographic proximity suggests indirect transmission between farms by fomites with differences between regions east and west of the river Meuse. Phylogenetic analysis of calf isolates with isolates from public databases indicates transitions from bovine to human adaptation. These findings provide new means to further model the spread of E. coli in livestock farming.
- 17 November 2025
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 81 (1)
Synergistic but clinically unattainable: amoxicillin/ceftriaxone combination against ampicillin-susceptible Enterococcus faecium
Background: Infective endocarditis (IE) is a severe infection requiring efficient, sometimes combined, antibiotic therapy. For β-lactam–susceptible Enteroccus spp., particularly Enterococcus faecalis (EFS), the combination of amoxicillin and ceftriaxone is currently recommended. However, limited data are available for ampicillin-susceptible E. faecium strains (EFM-S). Objectives: To characterize the in vitro synergy of amoxicillin/ceftriaxone combination against clinical isolates of EFM-S and evaluate its clinical relevance. Methods: Twenty-six EFM-S and 10 EFS clinical isolates from the Henri Mondor Hospital (Créteil, France) were tested. EFM-S clades were previously determined by whole-genome sequencing. Checkerboard assays were performed to assess the MICs and synergy across a range of amoxicillin and ceftriaxone concentrations. The fractional inhibitory concentration (FIC) index was computed for each combination, with synergy defined as ΣFIC ≤ 0.5. Results: Amoxicillin and ceftriaxone MIC distributions were comparable between EFM-S (amoxicillin, 0.06–2 mg/L; ceftriaxone, 1 to ≥1024 mg/L) and EFS (amoxicillin, 0.5–2 mg/L; ceftriaxone, 64 to ≥1024 mg/L). Synergy was observed in 21/26 EFM-S and all EFS strains. The five non-synergistic EFM-S strains had low ceftriaxone MICs (1–16 mg/L), probably limiting synergy detection. No difference was observed according to EFM clades. The minimal synergistic concentrations were consistently higher for EFM-S (median amoxicillin, 0.125 mg/L; ceftriaxone, 32 mg/L) compared to EFS (amoxicillin, 0.03 mg/L; ceftriaxone, 2 mg/L). Conclusions: Despite in vitro synergy, the amoxicillin/ceftriaxone combination is clinically irrelevant for EFM-S IE due to unachievable drug concentrations in vivo. These findings support clearer guidelines explicitly excluding this regimen for E. faecium, regardless of β-lactam susceptibility.
- 17 November 2025
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 81 (1)
Synergistic but clinically unattainable: amoxicillin/ceftriaxone combination against ampicillin-susceptible Enterococcus faecium
Background: Infective endocarditis (IE) is a severe infection requiring efficient, sometimes combined, antibiotic therapy. For β-lactam–susceptible Enteroccus spp., particularly Enterococcus faecalis (EFS), the combination of amoxicillin and ceftriaxone is currently recommended. However, limited data are available for ampicillin-susceptible E. faecium strains (EFM-S). Objectives: To characterize the in vitro synergy of amoxicillin/ceftriaxone combination against clinical isolates of EFM-S and evaluate its clinical relevance. Methods: Twenty-six EFM-S and 10 EFS clinical isolates from the Henri Mondor Hospital (Créteil, France) were tested. EFM-S clades were previously determined by whole-genome sequencing. Checkerboard assays were performed to assess the MICs and synergy across a range of amoxicillin and ceftriaxone concentrations. The fractional inhibitory concentration (FIC) index was computed for each combination, with synergy defined as ΣFIC ≤ 0.5. Results: Amoxicillin and ceftriaxone MIC distributions were comparable between EFM-S (amoxicillin, 0.06–2 mg/L; ceftriaxone, 1 to ≥1024 mg/L) and EFS (amoxicillin, 0.5–2 mg/L; ceftriaxone, 64 to ≥1024 mg/L). Synergy was observed in 21/26 EFM-S and all EFS strains. The five non-synergistic EFM-S strains had low ceftriaxone MICs (1–16 mg/L), probably limiting synergy detection. No difference was observed according to EFM clades. The minimal synergistic concentrations were consistently higher for EFM-S (median amoxicillin, 0.125 mg/L; ceftriaxone, 32 mg/L) compared to EFS (amoxicillin, 0.03 mg/L; ceftriaxone, 2 mg/L). Conclusions: Despite in vitro synergy, the amoxicillin/ceftriaxone combination is clinically irrelevant for EFM-S IE due to unachievable drug concentrations in vivo. These findings support clearer guidelines explicitly excluding this regimen for E. faecium, regardless of β-lactam susceptibility.
- Open Access
Influence of iron uptake systems on cefiderocol activity in Escherichia coli : at the crossroads of antibiotic resistance and virulence
Cefiderocol (FDC) is a new siderophore-conjugated cephalosporin that enters the periplasm via iron transport systems. However, the specific contribution of individual iron uptake pathways to FDC activity remains unclear. We investigated the role of 12 iron acquisition systems using several Escherichia coli strain collections. FDC MICs were determined in iron-depleted and iron-supplemented media for E. coli mutants (Keio and pathogenic island [PAI]-deleted collections) and for clinical wild-type or TEM-producing E. coli (WT/TEM- Ec ) and NDM-producing (NDM- Ec ) isolates. The distribution of iron uptake genes was assessed in these isolates. In addition, fec operon prevalence and genomic location were investigated in E. coli genomes from EnteroBase and RefSeq databases. Among Keio and 536-PAI-deleted mutants, only Δ cirA and Δ fiu (enterobactin system) showed increased FDC MICs (8- and 3-fold, respectively), while Δ fecA and Δ fecB had lower MICs (3-fold decrease). The fec operon, a known extraintestinal virulence factor, was significantly more prevalent in isolates with FDC MICs above median than in those with MICs below (94% vs . 38% in WT/TEM- Ec ; 100% vs . 0% in NDM- Ec ). According to EUCAST breakpoints, 66.7% of fec -positive NDM- Ec were resistant to FDC while none of the fec -negative were. The fec operon was found in 46.5% of E. coli genomes, including virulent clones (ST131, 77%) and was mostly chromosome-borne (99%). Plasmid-borne fec closely resembled that of Enterobacter hormaechei , suggesting interspecies transfer. Our findings highlight the role of Fec in reducing FDC susceptibility and promoting resistance in NDM-producing E. coli . They challenge the virulence-resistance trade-off demonstrating the ‘liaisons dangereuses’ between iron and antibiotics.
Open AccessInfluence of iron uptake systems on cefiderocol activity in Escherichia coli : at the crossroads of antibiotic resistance and virulence
Cefiderocol (FDC) is a new siderophore-conjugated cephalosporin that enters the periplasm via iron transport systems. However, the specific contribution of individual iron uptake pathways to FDC activity remains unclear. We investigated the role of 12 iron acquisition systems using several Escherichia coli strain collections. FDC MICs were determined in iron-depleted and iron-supplemented media for E. coli mutants (Keio and pathogenic island [PAI]-deleted collections) and for clinical wild-type or TEM-producing E. coli (WT/TEM- Ec ) and NDM-producing (NDM- Ec ) isolates. The distribution of iron uptake genes was assessed in these isolates. In addition, fec operon prevalence and genomic location were investigated in E. coli genomes from EnteroBase and RefSeq databases. Among Keio and 536-PAI-deleted mutants, only Δ cirA and Δ fiu (enterobactin system) showed increased FDC MICs (8- and 3-fold, respectively), while Δ fecA and Δ fecB had lower MICs (3-fold decrease). The fec operon, a known extraintestinal virulence factor, was significantly more prevalent in isolates with FDC MICs above median than in those with MICs below (94% vs . 38% in WT/TEM- Ec ; 100% vs . 0% in NDM- Ec ). According to EUCAST breakpoints, 66.7% of fec -positive NDM- Ec were resistant to FDC while none of the fec -negative were. The fec operon was found in 46.5% of E. coli genomes, including virulent clones (ST131, 77%) and was mostly chromosome-borne (99%). Plasmid-borne fec closely resembled that of Enterobacter hormaechei , suggesting interspecies transfer. Our findings highlight the role of Fec in reducing FDC susceptibility and promoting resistance in NDM-producing E. coli . They challenge the virulence-resistance trade-off demonstrating the ‘liaisons dangereuses’ between iron and antibiotics.